Equity Research, Broker Reports, and media content on GALAPAGOS NV

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about GALAPAGOS NV
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on GALAPAGOS NV. We currently have 0 research reports from 0 professional analysts.

Open
65.0
Volume
0.3m
Range
64.6/65.6
Market Cap
3,001,557,133m
52 Week
35.4/67.0
Date Source Announcement
22Mar17 06:31 GNW Galapagos initiates Phase 1 study with novel CF potentiator GLPG3067
10Mar17 06:30 GNW New Phase 2 studies with filgotinib in small bowel and fistulizing Crohn's disease
23Feb17 21:00 GNW Galapagos doses first healthy volunteer with CF combo GLPG2222 and GLPG2451
23Feb17 21:00 GNW Galapagos reports strong financial results and newsflow-rich pipeline
  • Frequency of research reports

     

  • Research reports on

    GALAPAGOS NV

  • Providers covering

    GALAPAGOS NV